The firm's platform combines single-cell microbiology and machine learning to deliver a result in four to six hours.
Epic Sciences Raises $24M, Expands Commercial Infrastructure for Breast Cancer Liquid Biopsy Test
The firm is growing its sales, product marketing, and customer service teams for its multiomic metastatic breast cancer liquid biopsy test, DefineMBC.
4D Lifetec Raises $1.9M in Series B Financing to Support Lung Cancer Detection Test Launch
The company is hoping to accelerate its activities in Europe and is preparing to bring the cell-based test to the US by the end of next year.
Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing
Fluidigm tallied $39.9 million in revenues compared to $26.5 million a year ago, and well above analysts' consensus estimate of $32.5 million.
BioSkryb, St. Jude Expand Licensing Deal for Dx Applications of Single-Cell Tech
BioSkryb will now have an exclusive global license for clinical applications of primary template directed amplification technology.
May 6, 2020
Bio-Rad Q1 Revenues Rise 3 Percent
May 17, 2018